Bai lituan, a lawyer, passed the unified qualification examination in October 1997. He has successively worked in Construction Engineering Group and Shanghai Fosun Group. His main professional fields are real estate / construction engineering litigation and arbitration, equity related dispute resolution and merger and reorganization.
• Member of M & a committee of Shanghai Lawyers Association
• The arbitrator of the Wuxi Arbitration commission
• Arbitrators of Jingdezhen Arbitration Commission and Jingdezhen International Arbitration Court
• Master of W. P. Kerry School of business, Arizona State University, USA
• Master of East China University of science and technology
• Jiangxi University of Finance and Economics
• Legal qualification
• Accountant qualification
He has published more than 50 professional articles in the magazine of the board of directors, Shanghai lawyers, financial and accounting news, China industry and Commerce News and other media. Among them, "intellectual property disputes: apple is a good teacher" was included in "people's livelihood 2012 reading selection" by Shanghai Library, and "judicial protection of non original databases under the information network environment" and other six articles were included in the series of "information network and high-tech legal frontier" compiled by the National Association of lawyers.
In terms of equity litigation, he has acted as an agent in many equity related cases, involving equity transfer disputes, expulsion of shareholders, preemptive right of equity, equity confirmation, request for change of company registration, request for profit distribution, share repurchase, etc.
In terms of equity acquisition, it has undertaken dozens of major acquisition projects, including the acquisition of a real estate company in Yangzhou by Evergrande real estate group, the acquisition of a steel structure Co., Ltd. by Poulos logistics company, the landing of China Hengtian new energy car in Nanjing, and the joint venture of Shanghai Pharmaceutical (sh601607) and kangxinuo (hk6185) to establish the novel coronavirus vaccine (adenovirus vector) production base project in Shanghai.
The customers who have been served for many years include well-known listed companies such as Shanghai Steel Union (300226, SZ), Shanghai Pharmaceutical (601607, SH), Fosun International (00656, HK), and well-known enterprises in the industry such as Yousheng technology, Haizhi construction, meigulong China, China Taiping Insurance, etc.